Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Di Zhang, Song Li, Wenbin Yu, Cheng Chen, Teng Liu, Yiting Sun, Zeyi Zhao & Lian Liu. (2018) LIMD1 is a survival prognostic marker of gastric cancer and hinders tumor progression by suppressing activation of YAP1. Cancer Management and Research 10, pages 4349-4361.
Read now
Read now
Articles from other publishers (5)
Zitong Wang, Yingying Chen, Xiaoyu Li, Yuhan Zhang, Xiaokun Zhao, Hao Zhou, Xuebo Lu, Lili Zhao, Qiang Yuan, Yunshu Shi, Jimin Zhao, Ziming Dong, Yanan Jiang & Kangdong Liu. (2022) Tegaserod Maleate Suppresses the Growth of Gastric Cancer In Vivo and In Vitro by Targeting MEK1/2. Cancers 14:15, pages 3592.
Crossref
Crossref
Xuguang Jiao, Yu Wang, Feng Wang & Xinbo Wang. (2020) Recurrence pattern and its predictors for advanced gastric cancer after total gastrectomy. Medicine 99:51, pages e23795.
Crossref
Crossref
Fanming Kong, Fangfang Gao, Jun Chen, Rongxiu Zheng, Honggen Liu, Xiaojiang Li, Peiying Yang, Geli Liu & Yingjie Jia. (2016) Elevated serum C-reactive protein level predicts a poor prognosis for recurrent gastric cancer. Oncotarget 7:34, pages 55765-55770.
Crossref
Crossref
F. Kong, Y. Qi, H. Liu, F. Gao, P. Yang, Y. Li & Y. Jia. (2015) Surgery combined with chemotherapy for recurrent gastric cancer achieves better long-term prognosis. Clinical and Translational Oncology 17:11, pages 917-924.
Crossref
Crossref
CHANGJIANG LUO, ZHIXING DU, XING WEI, GANG CHEN & ZHONGXUE FU. (2015) Bisdemethoxycurcumin attenuates gastric adenocarcinoma growth by inducing mitochondrial dysfunction. Oncology Letters 9:1, pages 270-274.
Crossref
Crossref